Skip to main content

Table 2 Plasma levels of biomarkers

From: Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension

 

CTRL

MCT

SAL

MSC

SAL

MSC

VEGF (pg/μg)

117.2 ± 39.4

135.9 ± 156.3

29.5 ± 23.0#

1.9 ± 1.3†

PDGF (pg/μg)

508.7 ± 205.2

520.7 ± 338.0

343.0 ± 239.0

458.1 ± 365.9

  1. Plasma levels of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) at 28 days. Results normalized by total protein content (Bradford’s technique) as picograms per microgram. Values presented as mean ± SD of seven animals/group
  2. CTRL control, MCT monocrotaline, SAL saline
  3. #Significantly different from CTRL-SAL at 28 days (p < 0.0167)
  4. †Significantly different from MCT-SAL at 28 days (p < 0.0167)